BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 333455)

  • 1. Interaction of coagulation factor Xa with human platelets.
    Miletich JP; Jackson CM; Majerus PW
    Proc Natl Acad Sci U S A; 1977 Sep; 74(9):4033-6. PubMed ID: 333455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMEM16E regulates endothelial cell procoagulant activity and thrombosis.
    Schmaier AA; Anderson PF; Chen SM; El-Darzi E; Aivasovsky I; Kaushik MP; Sack KD; Hartzell HC; Parikh SM; Flaumenhaft R; Schulman S
    J Clin Invest; 2023 Jun; 133(11):. PubMed ID: 36951953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet procoagulant membrane dynamics: a key distinction between thrombosis and hemostasis?
    Agbani EO; Hers I; Poole AW
    Blood Adv; 2023 Apr; 7(8):1615-1619. PubMed ID: 36574232
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of cold storage on platelets treated with Intercept pathogen inactivation.
    Six KR; Devloo R; Compernolle V; Feys HB
    Transfusion; 2019 Aug; 59(8):2662-2671. PubMed ID: 31187889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation.
    Larson MK; Tormoen GW; Weaver LJ; Luepke KJ; Patel IA; Hjelmen CE; Ensz NM; McComas LS; McCarty OJ
    Am J Physiol Cell Physiol; 2013 Feb; 304(3):C273-9. PubMed ID: 23174566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prothrombin activation by platelet-associated prothrombinase proceeds through the prethrombin-2 pathway via a concerted mechanism.
    Haynes LM; Bouchard BA; Tracy PB; Mann KG
    J Biol Chem; 2012 Nov; 287(46):38647-55. PubMed ID: 22989889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-associated anti-Xa activity and platelet-derived prothrombotic and proinflammatory biomarkers in moderate to high-risk patients with acute coronary syndrome.
    Becker RC; Mahaffey KW; Yang H; Marian AJ; Furman MI; Michael Lincoff A; Hazen SL; Petersen JL; Reist CJ; Kleiman NS;
    J Thromb Thrombolysis; 2011 Feb; 31(2):146-53. PubMed ID: 21086021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-mediated control of blood coagulation: the role of binding site densities and platelet deposition.
    Kuharsky AL; Fogelson AL
    Biophys J; 2001 Mar; 80(3):1050-74. PubMed ID: 11222273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human coagluation factor V purification and thrombin-catalyzed activation.
    Dahlbäck B
    J Clin Invest; 1980 Sep; 66(3):583-91. PubMed ID: 7400329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between platelet secretion and prothrombin cleavage in native whole blood.
    Rybak ME; Lau HK; Tomkins B; Rosenberg RD; Handin RI
    J Clin Invest; 1981 Aug; 68(2):405-12. PubMed ID: 7263860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells.
    Schwartz BS; Levy GA; Curtiss LK; Fair DS; Edgington TS
    J Clin Invest; 1981 Jun; 67(6):1650-8. PubMed ID: 7240413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of lipid-protein particles containing platelet factor 3 released from human platelets.
    Sandberg H; Andersson LO; Höglund S
    Biochem J; 1982 Apr; 203(1):303-11. PubMed ID: 7103943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin increases expression of fibronectin antigen on the platelet surface.
    Ginsberg MH; Painter RG; Forsyth J; Birdwell C; Plow EF
    Proc Natl Acad Sci U S A; 1980 Feb; 77(2):1049-53. PubMed ID: 6987662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization and secretion of factor V from human platelets.
    Chesney CM; Pifer D; Colman RW
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5180-4. PubMed ID: 6946465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of membrane proteins mediating the interaction of human platelets.
    Phillips DR; Jennings LK; Edwards HH
    J Cell Biol; 1980 Jul; 86(1):77-86. PubMed ID: 6893455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.
    Thiagarajan P; Shapiro SS; De Marco L
    J Clin Invest; 1980 Sep; 66(3):397-405. PubMed ID: 6772673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of coagulation factor V by a platelet protease.
    Kane WH; Mruk JS; Majerus PW
    J Clin Invest; 1982 Nov; 70(5):1092-100. PubMed ID: 6752201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.
    Sinha D; Seaman FS; Koshy A; Knight LC; Walsh PN
    J Clin Invest; 1984 Jun; 73(6):1550-6. PubMed ID: 6609936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding of factors IX and IXa to cultured vascular endothelial cells.
    Stern DM; Drillings M; Nossel HL; Hurlet-Jensen A; LaGamma KS; Owen J
    Proc Natl Acad Sci U S A; 1983 Jul; 80(13):4119-23. PubMed ID: 6602986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prothrombin is activated on vascular endothelial cells by factor Xa and calcium.
    Rodgers GM; Shuman MA
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):7001-5. PubMed ID: 6580622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.